India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
What is Google Bard AI, and how is it different from ChatGPT? New inventions have not ended in the world of technology. Let us tell you that now Google has launched its AI Technology Bard. The reason for launching it is to compete with Chat GPT-3. Due to this, it is being brought to the market so quickly. Google CEO Sundar Pichai himself gave this information by posting an official blog. He told that with its arrival, the difficult tasks of the people will be done easily. At present, the company has only released a few of its testers. After this, if it is successful, then it will be launched in the market as soon as possible. Let's know some special things about it.